Amini RM - Search Results

1

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.

Zhou W, Jirström K, Amini RM, Fjällskog ML, Sollie T, Lindman H, Sørlie T, Blomqvist C, Wärnberg F. Zhou W, et al. Among authors: amini rm. BMC Cancer. 2013 Oct 30;13:512. doi: 10.1186/1471-2407-13-512. BMC Cancer. 2013. PMID: 24171825 Free PMC article.

2

Mast cells and eosinophils in invasive breast carcinoma.

Amini RM, Aaltonen K, Nevanlinna H, Carvalho R, Salonen L, Heikkilä P, Blomqvist C. Amini RM, et al. BMC Cancer. 2007 Aug 29;7:165. doi: 10.1186/1471-2407-7-165. BMC Cancer. 2007. PMID: 17727696 Free PMC article.

3

Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.

Aaltonen K, Amini RM, Landberg G, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H, Blomqvist C. Aaltonen K, et al. Among authors: amini rm. Breast Cancer Res Treat. 2009 Jan;113(1):75-82. doi: 10.1007/s10549-008-9908-5. Epub 2008 Feb 1. Breast Cancer Res Treat. 2009. PMID: 18240019

4

Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.

Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H. Aaltonen K, et al. Among authors: amini rm. Clin Cancer Res. 2008 Apr 1;14(7):1976-83. doi: 10.1158/1078-0432.CCR-07-4100. Clin Cancer Res. 2008. PMID: 18381935

5

Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer.

Ahlin C, Zhou W, Holmqvist M, Holmberg L, Nilsson C, Jirström K, Blomqvist C, Amini RM, Fjällskog ML. Ahlin C, et al. Among authors: amini rm. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2501-6. doi: 10.1158/1055-9965.EPI-09-0169. Epub 2009 Aug 25. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19706846 Free article.

6

[Ki-67 and cyclin A--prognostic factors in breast cancer. Time to introduce proliferation markers in clinical routine].

Ahlin C, Fernö M, Amini RM, Tolockiene E, Blomqvist C, Bergh J, Fjällskog ML. Ahlin C, et al. Among authors: amini rm. Lakartidningen. 2010 Mar 10-16;107(10):672-5. Lakartidningen. 2010. PMID: 20402250 Review. Swedish. No abstract available.

7

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.

Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F. Muggerud AA, et al. Among authors: amini rm. Mol Oncol. 2010 Aug;4(4):357-68. doi: 10.1016/j.molonc.2010.06.007. Epub 2010 Jun 26. Mol Oncol. 2010. PMID: 20663721 Free PMC article.

8

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.

Zhou W, Jirström K, Johansson C, Amini RM, Blomqvist C, Agbaje O, Wärnberg F. Zhou W, et al. Among authors: amini rm. BMC Cancer. 2010 Nov 30;10:653. doi: 10.1186/1471-2407-10-653. BMC Cancer. 2010. PMID: 21118480 Free PMC article.

9

Inflammatory cells in node-negative breast cancer.

Löfdahl B, Ahlin C, Holmqvist M, Holmberg L, Zhou W, Fjällskog ML, Amini RM. Löfdahl B, et al. Among authors: amini rm. Acta Oncol. 2012 May;51(5):680-6. doi: 10.3109/0284186X.2011.652737. Epub 2012 Jan 24. Acta Oncol. 2012. PMID: 22268578

10

Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.

Nilsson C, Johansson I, Ahlin C, Thorstenson S, Amini RM, Holmqvist M, Bergkvist L, Hedenfalk I, Fjällskog ML. Nilsson C, et al. Among authors: amini rm. Acta Oncol. 2013 Jan;52(1):102-9. doi: 10.3109/0284186X.2012.711952. Epub 2012 Aug 29. Acta Oncol. 2013. PMID: 22928693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page